Wrinkles

0
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Anika Therapeutics
Anika TherapeuticsMA - Bedford
1 program
ElevessN/A1 trial
Active Trials
NCT01147172CompletedEst. Aug 2010
Lumenis
LumenisAustralia - Chatswood
1 program
M22 ResurFX moduleN/A1 trial
Active Trials
NCT01796626Completed36Est. Jul 2014
Century Therapeutics
Century TherapeuticsPHILADELPHIA, PA
1 program
PDO sutureN/A1 trial
Active Trials
NCT07068061Not Yet Recruiting50Est. Jul 2026
Deka Biosciences
Deka BiosciencesMD - Germantown
1 program
TriActive+ RFN/A1 trial
Active Trials
NCT01460927CompletedEst. Apr 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Century TherapeuticsPDO suture
LumenisM22 ResurFX module
Deka BiosciencesTriActive+ RF
Anika TherapeuticsElevess

Clinical Trials (4)

Total enrollment: 86 patients across 4 trials

NCT07068061Century TherapeuticsPDO suture

PER-SAF_PDOS (Performance and Safety of Polydioxanone Suture)

Start: Sep 2025Est. completion: Jul 202650 patients
N/ANot Yet Recruiting
NCT01796626LumenisM22 ResurFX module

Clinical Evaluation of M22 ResurFX 1565nm Module

Start: Dec 2012Est. completion: Jul 201436 patients
N/ACompleted
NCT01460927Deka BiosciencesTriActive+ RF

TriActive+ Radiofrequency (RF) for Non-invasive Treatment of Wrinkles & Rhytides

Start: Oct 2011Est. completion: Apr 2012
N/ACompleted
NCT01147172Anika TherapeuticsElevess

Safety Study of Cosmetic Tissue Augmentation in People of Color

Start: Mar 2009Est. completion: Aug 2010
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space